Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Wellbeing Digital Sciences Inc (OP: KONEF ) N/A UNCHANGED Last Price Updated: 3:57 PM EST, Mar 6, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Wellbeing Digital Sciences Inc < Previous 1 2 Next > Wellbeing Digital Subsidiary KGK Science to Participate at the Mushroom Summit and Psychedelic Science Conference June 19, 2023 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Digital Enters into Share Purchase Agreement with Cardinal Group June 16, 2023 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Digital Subsidiary KGK Science to Participate at the Nutrition Industry Association Spring Conference May 25, 2023 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Subsidiary KGK Science Announces Successful Results of UP360, a Nutraceutical Ingredient Demonstrating Beneficial Immune Defense Response May 03, 2023 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Subsidiary KGK Science Begins Recruitment in First-of-its-Kind Health Canada Approved Psilocybin Trial April 18, 2023 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Subsidiary KGK Science Receives Institutional Review Board Approval April 11, 2023 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Announces Cease Trade Order April 06, 2023 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Provides Bi-Weekly Default Status Report March 16, 2023 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Digital to Participate at the Benzinga Psychedelic Capital Conference March 16, 2023 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Digital to Participate at the Cantor Fitzgerald Virtual Panel Discussion March 13, 2023 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Digital to Participate in The Global Biomedical Design Conference March 09, 2023 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Subsidiary KGK Science Applies for a Controlled Substances Dealers License and Receives Approval to Proceed with Buildout March 08, 2023 From WELLBEING DIGITAL SCIENCES Via Business Wire Wellbeing Provides Bi-Weekly Default Status Report March 02, 2023 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Digital to Participate in MarigoldLIVE: International Women’s Day Networking Event March 01, 2023 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Provides Bi-Weekly Default Status Report February 16, 2023 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Subsidiary KGK Science Announces Publication of Safety Studies on Paraxanthine and Comparison to Caffeine Toxicity. February 15, 2023 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Subsidiary KGK Science Receives Exemption Under Section 56 of the Controlled Drugs and Substances Act to Begin Psilocybin Clinical Trial February 14, 2023 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Announces Delay in Filing Its Financial Statements and Management Cease Trade Order February 01, 2023 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Digital to Participate in the Psychedelic Medicine Association Webinar January 25, 2023 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Digital Announces Change of Auditor January 18, 2023 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Subsidiary KGK Science Receives Approval for First-of-its-Kind Psylocibin Clinical Trial December 22, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Subsidiary KGK Science Awarded Cannabis Research License from Health Canada December 08, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Subsidiary KGK Science Announces Successful Results of UP446, a Nutraceutical Ingredient, in Positive Immune Defense Response December 06, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Subsidiary KGK Science Submits CTA for Phase IIA Clinical Trial November 30, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Subsidiary Mindscape Treats its 1,000th Patient November 29, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Digital Announces the Appointment of Mohammad Sharifi to Board of Directors November 22, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Digital Announces Resignation of Directors November 18, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Subsidiary KGK Science Enters into Research Contract With Nova Mentis for Phase II A Clinical Trial November 17, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Subsidiary KGK Science Announces Successful Delivery of CBD and THC Through the Skin of Healthy Volunteers November 14, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire Wellbeing Digital Subsidiary KGK to Participate in Microdose Wonderland Miami Conference November 02, 2022 From Wellbeing Digital Sciences Inc. Via Business Wire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.